- Round ID
- FR-00312
- Stage
- Series D
- Round name
- Series D
- Amount
- $80M / £61.7M
Dated funding evidence
Huma Therapeutics
Series D · $80M / £61.7M · 2024-07-16
Reported round$80M / £61.7MSeries D
- Disclosure date
- 2024-07-16
- Reported currency
- USD
- Companies House
- 07725451
- Evidence sources
- 5
Company
Huma TherapeuticsCH 077254512024-07-16Series D$80M / £61.7M
Resolved investor records
Investor links inherit this round’s named source and date. Resolved links use an exact canonical investor name; unresolved names remain unlinked.
Record fields
What the source states
Amounts, currency, stage and investor names are preserved as reported. No FX conversion, valuation inference or current-holding claim is added.
- Lead investors
- Not stated
- Other investors
- AstraZeneca, HAT Technology Fund 4, Hitachi Ventures, Leaps by Bayer
- Source layers
- VC research snapshot, Live Chris T D1
- Snapshot
- 2026-08-25
Named evidence
Source trail
This page is published only when the record has a resolved company, disclosure date, round stage and at least one retained source URL.